← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV14행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyStandard DatabasestalePhase 1
Quadrivalent Inactivated Influenza Vaccine (Quadrivalent Inactivated Influenza Vaccine)
Carlo Contreras·Clinical Stage I Cutaneous Melanom…
31 trials
Overview
Program
Quadrivalent Inactivated Influenza Vaccine
Overview
Company
Carlo Contreras
Overview
Modality
ANTIBODY
Overview
Target
Clinical Stage I Cutaneous Melanoma AJCC
Overview
Indication
Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8
Overview
Phase
PHASE_1
Overview
Status
RECRUITING
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Watch
Overview
Approval status
Investigational
Toxicology
Major finding
Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.. Influenza vaccines for those aged <9 years old are limited to the standard-dose inactivated influenza vaccine (IIV) and live-attenuated intranasal influenza vaccine. In this Phase III, modified double-blind,…
Clinical
Safety signal
Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.. Influenza vaccines for those aged <9 years old are limited to the standard-dose inactivated influenza vaccine (IIV) and live-attenuated intranasal influenza vaccine. In this Phase III, modified double-blind,…
Clinical
Program phase
PHASE_1